AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$7.01
+0.11 (+1.59%)
As of Aug 15, 2:17 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +443.9% upside
Low Target $23.34
Average Target $38.13
High Target $40.06
Current Price $7.01
Current
$7.01
Target
$38.13
$23.34 $38.13 avg $40.06
Scenario Analysis
Bear Case
$23.34
233.0%
Low target
Base Case
$38.13
+443.9%
Avg target
Bull Case
$40.06
+471.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$8.85
-20.8% from high
52-Week Low
$2.71
+158.7% from low
Target vs 52W High
$38.13
+330.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%